TABLE 1.

Reporting of MSLT-II criteria and clinically actionable recommendations in melanoma nodal surveillance ultrasonography

Variable	Normal ultrasound [n = 215]	Abnormal ultrasound [n = 54]	Total [N = 269]	p-Value
MSLT-II criteria reported
0	182 (84.7)	6 (11.1)	188 (69.9)	< 0.0001
1	28 (13.0)	20 (37.0)	48 (17.8)
2	2 (1.0)	15 (27.8)	17 (6.3)
3	3 (1.4)	13 (24.1)	16 (6.0)
Clinically actionable recommendation made
Continue surveillance	204 (94.9)	27 (50.0)	231 (85.9)	< 0.0001
Biopsy	0 (0.0)	8 (14.8)	8 (2.9)
Combined	204 (94.9)	35 (64.8)	239 (88.8)

Variables are expressed as frequency (%)

MSLT-II Second Multicenter Selective Lymphadenectomy Trial